AKBA – akebia therapeutics, inc. (US:NASDAQ)

News

Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Akebia Therapeutics (AKBA) was downgraded by Zacks Research from "hold" to "strong sell".
Akebia Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
Akebia Therapeutics: Q4 Earnings Snapshot [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com